Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

0.5099
Delayed Data
As of Apr 29
 -0.0001 / -0.02%
Today’s Change
0.39
Today|||52-Week Range
0.90
-25.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues5.3M5.2M3.8M3.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses583.0K516.0K213.0K838.0K
 
 
 
 
 
Total Operating Expenses583.0K516.0K213.0K838.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income4.7M4.7M3.6M2.3M
 
 
 
 
 
Extraordinary Credit0.000.000.0046.0K
 
 
Extraordinary Charge0.000.00-4.6M0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.7M4.7M-926.0K2.4M
 
 
 
 
 
Income Taxes-2.5M-894.0K-888.0K-10.1M
 
 
 
 
 
Net Income7.2M3.8M-1.8M12.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.2M44.2M44.2M44.2M
 
 
 
 
 
Shares To Calculate EPS Diluted44.2M44.2M44.2M44.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.16$0.09-$0.04$0.28
 
 
 
 
 
EPS Diluted$0.16$0.09-$0.04$0.28